Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes

Vatankulu, B.; Aksoy, S.; Asa, S.; Sager, S.; Sayman, H.; Halac, M.; Sonmezoglu, K.

doi:10.1016/j.remn.2015.07.001

Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes

Vatankulu B., Aksoy S. Y., Asa S., Sager S., Sayman H. B., Halac M., ...More

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, vol.35, no.1, pp.17-21, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 35 Issue: 1
Publication Date: 2016
Doi Number: 10.1016/j.remn.2015.07.001
Journal Name: REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.17-21
Istanbul University Affiliated: Yes

Abstract

Objective: There is still no consensus about whether to perform PET/CT to detect carcinoma in paraneoplastic neurological syndromes (PNS) in patients with or without antibodies. The aim of this study is to determine the diagnostic accuracy of PET/CT and antibodies in patients with PNS.